Table 1 |
|
|
Characteristics of the study population |
|
|
N |
67 |
|
Average age in years (Range) |
48.9 (18 – 69) |
|
Gender (% female) |
83 |
|
White (%) |
6 |
|
Black (%) |
81 |
|
Other (%) |
13 |
|
Ex-smokers n (%) |
21 (33%) |
|
Average Pack-per-year (95% C.I.) |
4 (2 – 5) |
|
Average body weight in pounds (95% C.I.) |
198 (186 – 209) |
|
Average BMI (95% C.I.) |
32 (31 – 35) |
|
Normal weight (BMI ≥ 18 ≤ 25) (%) |
14 |
|
Overweight (BMI > 25 < 30) |
28 |
|
Obese (BMI ≥ 30) |
58 |
|
Average waist/hip ratio (95% C.I.) |
0.87 (0.85 – 0.9) |
|
Diabetes (%) |
18 |
|
GERD treatment (%) |
60 |
|
Hypertension (%) |
45 |
|
Obstructive sleep apnea (%) |
12 |
|
Average FEV1 (95% C.I.) |
2.1 (2.0 – 2.3) |
|
Average FVC (95% C.I.) |
2.8 (2.6 – 3.0) |
|
Average FEV1/FVC (95% C.I.) |
0.80 (0.7 – 0.8) |
|
Average FRC (95% C.I.) |
3.2 (2.8 – 3.5) |
|
Average Exhaled NO (95% C.I.) (ppb)* |
25 (19 – 30) |
|
Average Exhaled 8-isoprostanes (95% C.I.) (pg/ml) |
11 (9.6 – 12.4) |
|
Average Adiponectin (μg/ml) (95% C.I.) |
3 (2.9 – 3.4) |
|
Average Leptin (ng/ml) (95% C.I.) |
15 (12 – 18) |
|
|
|
|
BMI (Body mass index), FEV1 (Forced exhalation volume in one second), GERD (Gastro esophageal reflux disease), FRC (Functional Residual Capacity), Plasma adipokines were available for 50 asthmatics. Exhaled 8-isoprostanes were available for 56 asthmatics. |
|
|
Komakula et al. Respiratory Research 2007 8:32 doi:10.1186/1465-9921-8-32 |
|
